Bourdin A, Papi AA, Corren J, Virchow JC, et al. Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline. Allergy 2020 Oct 3. doi: 10.1111/all.14611.
PMID: 33010038